Boardman Bethany K, He Ming, Ouyang Zhiming, Xu Haijun, Pang Xiujuan, Yang X Frank
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
Infect Immun. 2008 Sep;76(9):3844-53. doi: 10.1128/IAI.00467-08. Epub 2008 Jun 23.
Alteration of surface lipoprotein profiles is a key strategy that the Lyme disease pathogen, Borrelia burgdorferi, has evolved to be maintained within its enzootic cycle between arthropods and mammals. Accumulated evidence indicates that the central regulatory pathway controlling differential gene expression by B. burgdorferi is the RpoN-RpoS pathway (the sigma(54)-sigma(S) sigma factor cascade). It was previously shown that activation of the RpoN-RpoS pathway is controlled by Rrp2, a two-component response regulator and sigma(54)-dependent transcriptional activator. The role of Rrp2 in the infectious cycle of B. burgdorferi has not been determined heretofore. In this report, we demonstrate that an rrp2 mutant defective in activating sigma(54)-dependent transcription was unable to establish infection in mice, but the rrp2 mutant was capable of surviving within ticks during and after tick feeding. Because the rrp2 mutant was defective in the production of OspC, an outer surface lipoprotein essential for mammalian host infection, we further examined whether the loss of infectivity of the rrp2 mutant was solely due to the inability to produce OspC. While transformation with a shuttle vector carrying ospC under the control of a constitutive flaB promoter restored infection to an ospC mutant in immunodeficient SCID mice, it could not rescue the avirulent phenotype of the rrp2 mutant. These data indicate that, in addition to controlling OspC, Rrp2 controls another factor(s) essential for B. burgdorferi to establish infection in mammals. Furthermore, microarray analyses revealed that 125 and 19 genes were positively and negatively regulated, respectively, by Rrp2, which provides a foundation for future identification of additional Rrp2-dependent virulence determinants in B. burgdorferi.
表面脂蛋白谱的改变是莱姆病病原体伯氏疏螺旋体进化出的一种关键策略,以便在节肢动物和哺乳动物之间的生态循环中得以维持。越来越多的证据表明,控制伯氏疏螺旋体差异基因表达的核心调控途径是RpoN-RpoS途径(σ54-σS 因子级联反应)。先前的研究表明,RpoN-RpoS途径的激活受Rrp2控制,Rrp2是一种双组分反应调节因子和σ54 依赖性转录激活因子。迄今为止,Rrp2在伯氏疏螺旋体感染周期中的作用尚未确定。在本报告中,我们证明,一个在激活σ54 依赖性转录方面存在缺陷的rrp2突变体无法在小鼠中建立感染,但该rrp2突变体在蜱虫进食期间和之后能够在蜱虫体内存活。由于rrp2突变体在产生OspC方面存在缺陷,OspC是一种对哺乳动物宿主感染至关重要的外表面脂蛋白,我们进一步研究了rrp2突变体感染力的丧失是否仅仅是由于无法产生OspC。虽然用携带在组成型flaB启动子控制下的ospC的穿梭载体转化可恢复免疫缺陷的SCID小鼠中ospC突变体的感染能力,但它无法挽救rrp2突变体的无毒表型。这些数据表明,除了控制OspC外,Rrp2还控制伯氏疏螺旋体在哺乳动物中建立感染所必需的其他因素。此外,微阵列分析显示分别有125个和19个基因受Rrp2正向和负向调控,这为未来鉴定伯氏疏螺旋体中其他Rrp2依赖性毒力决定因素奠定了基础。